gip and glp 1 receptors glp-1 receptor agonist Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research Demonstrated metabolic effects of GIP glp 1 vs gip GLP-1

Bremelanotide also significantly reduced associated distress scores by 0.33 compared to placebo, addressing both the desire dimension and the emotional burden of low libido in research participants simultaneously

Nogueiras R, Nauck MA, Tschop MH

While GLP-1 receptor agonists (such as semaglutide and liraglutide) have demonstrated significant benefits in diabetes management, weight reduction, and cardiovascular outcomes in clinical trials, enhancing physiological GLP-1 through dietary and lifestyle modifications represents a foundational approach

Melanotan-2: Cyclic melanocortin peptide for tanning and sexual function